DAPLO v. DAPLOGIN: Delhi High Court Reaffirms Higher Protection for Pharmaceutical Marks
Delhi High Court | C.O. (COMM.IPD-TM) 122/2025 Decision: August 17, 2026 The article discusses rectification petition filed by Dr. Reddy’s Laboratories Limited (Dr Reddy’s) under Section 57 of the Trade Marks Act, 1999, seeking cancellation of Razenta Pharmaceuticals Private Limited’s (Razenta) registered trademark DAPLOGIN in Class 5. Dr. Reddy’s contended that DAPLOGIN is deceptively similar…
